Typically people with Cockayne’s syndrome live no longer than 20 years. Cockayne’s syndrome may be a very rare autosomal recessive disorder that may be associated with a genetic mutation, also known as microcephaly, striatal cerebellar calcification and protein dystrophy syndrome, or dwarf-retinal atrophy-deafness syndrome. Cockayne’s syndrome is characterized by the onset of the disease after two years of age, when the affected child is born normal and presents with developmental delay and later neurological deficits with microcephaly, tremor, and peripheral nerve palsy with an unsteady gait, as well as psychiatric developmental deficits. Usually affected children die from premature aging, cardiovascular disease, stroke, and other geriatric conditions. Cockayne’s syndrome has not been found to have a cure, usually commonly used some physical therapy methods, exercise therapy, etc., so that patients try to alleviate the pain caused by the disease, more communication with the patient, and positively face life, so as to prolong the survival time.